Updated
Updated · EurekAlert · Sep 22
Mizzou Study Reverses Age-Related Muscle Weakness in Animal Models, Targeting Protein Linked to Adults Over 80
Updated
Updated · EurekAlert · Sep 22

Mizzou Study Reverses Age-Related Muscle Weakness in Animal Models, Targeting Protein Linked to Adults Over 80

1 articles · Updated · EurekAlert · Sep 22

Summary

  • University of Missouri researchers found age-related muscle weakness stems partly from failing nerve-muscle communication, overturning the view that the neuromuscular junction stays reliable with aging.
  • Reduced NaV1.4 levels weakened the final step of signaling between nerves and muscles in both humans and animal models, the team reported in the Journal of Clinical Investigation.
  • By partially inhibiting the ClC-1 protein, researchers made aging muscles more responsive to nerve signals and improved muscle strength in an animal model, pointing to a potentially reversible mechanism.
  • Sarcopenia affects nearly half of adults over 80, and the finding could open a path to testing ClC-1-targeting drugs such as NMD Pharma's ignaseclant in older adults.

Insights

Could the secret to reversing age-related muscle weakness lie not in the muscles themselves, but in the hidden signals they receive?
If a new protein-blocking drug restores nerve-muscle communication, are we finally on the verge of curing age-related frailty forever?